However, the elicitation of higher magnitudes of CD4+ T cells by the DNA prime/MVA+gp120 protein boost vaccine could also be a concern for HIV vaccine development because responding CD4+ T cells have been hypothesized to enhance infections (14, 20, 21). This evidence concerns the gene CD4 and infection.